Powder: -20°C for 3 years | In solvent: -80°C for 1 year
NSC781406是一种高效PI3K 和mTOR 抑制剂,其PI3Kα的IC50值为2 nM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 472 | 现货 | ||
5 mg | ¥ 947 | 现货 | ||
10 mg | ¥ 1,660 | 现货 | ||
25 mg | ¥ 2,970 | 现货 | ||
50 mg | ¥ 4,390 | 现货 | ||
100 mg | ¥ 6,290 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 1,370 | 现货 |
产品描述 | NSC781406 is a highly effective inhibitor of PI3K and mTOR (IC50: 2 nM for PI3Kα). |
靶点活性 | mTOR:5.4 nM, PI3Kγ:2.7 nM, PI3Kα:2 nM, PI3Kβ:9.4 nM, PI3Kδ:14 nM |
体外活性 | NSC781406 shows reasonable liver microsome stability. NSC781406 displays effective PI3K inhibition (PI3Kα IC50=2.0 nM) that translates into BEL-7404 cells proliferation inhibition (IC50=20 nM) and it also demonstrates cytotoxic activities against leukemia, non-small cell, lung cancer, colon cancer, central nervous system cancer, melanoma, ovarian cancer, renal cancer, prostate cancer, and breast cancer. It is effective against 60 cancer cell lines with a mean GI50 value of 65 nM and with a GI50 value of less than 10 nM against four cancer cell lines. |
体内活性 | NSC781406 is well tolerated at 30 mg/kg, with no observed mortality or significant reduction of body weight. NSC781406(30 mg/kg) treatment, causes statistically significant antitumor activity, in the xenograft models. It has a mean reduction in the relative tumor volume ratio of 52%. Sorafenib shows an inhibition ratio of 44% at 50 mg/kg . |
分子量 | 627.68 |
分子式 | C29H27F2N5O5S2 |
CAS No. | 1676893-24-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 150 mg/mL (238.98 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 1.5932 mL | 7.9658 mL | 15.9317 mL | 39.8292 mL |
5 mM | 0.3186 mL | 1.5932 mL | 3.1863 mL | 7.9658 mL | |
10 mM | 0.1593 mL | 0.7966 mL | 1.5932 mL | 3.9829 mL | |
20 mM | 0.0797 mL | 0.3983 mL | 0.7966 mL | 1.9915 mL | |
50 mM | 0.0319 mL | 0.1593 mL | 0.3186 mL | 0.7966 mL | |
100 mM | 0.0159 mL | 0.0797 mL | 0.1593 mL | 0.3983 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
NSC781406 1676893-24-5 PI3K/Akt/mTOR signaling PI3K mTOR Phosphoinositide 3-kinase Mammalian target of Rapamycin Inhibitor inhibit NSC 781406 NSC-781406 inhibitor